Trial intelligence / Profile preview

Low-volume versus high-volume polyethylene glycol bowel preparation for colonoscopy in hemodialysis patients

2019-004840-30Phase 4Terminated

Sponsor
Policlinico di Bari
Start
Oct 2020
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised, open-label trial of polyethylene glycol + citrate + simethicone and Selg Esse (2 arms), sponsored by Policlinico di Bari. Primary endpoint: Adequate bowel cleansing. Started Oct 2020; status: terminated.

02

Drugs

polyethylene glycol + citrate + simethiconeSelg Esse

Beyond the preview

Go deeper on 2019-004840-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-004840-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call